Evalve Announces Enrollment Completion Of The EVEREST Randomized Study

Evalve, Inc., the leader in the development of devices for the percutaneous repair of cardiac valves, announced the completion of randomized enrollment in the Endovascular Valve Edge-to-Edge REpair STudy (EVEREST), which is evaluating the MitraClip(R) system as a non-surgical repair option for patients suffering from mitral regurgitation (MR). MR is the most common type of heart valve insufficiency in the United States, affecting millions of people worldwide.